InsiderTrades

Form 4 for BSX Boston Scientific

Accepted 2024-05-13 00:00:00 ET · period of report 2024-05-10 · accession 0001225208-24-005975 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-05-13 2024-05-10 BSX Thepaut Eric Francis Yves EVP, Pres, Eur, Mid-East, Afr M - OptEx $16.31 +12.9K 44.4K +41% +$210.9K
D 2024-05-13 2024-05-10 BSX Thepaut Eric Francis Yves EVP, Pres, Eur, Mid-East, Afr S - Sale+OE $74.14 -12.9K 31.4K -29% -$958.7K
D 2024-05-13 2024-05-10 BSX Thepaut Eric Francis Yves EVP, Pres, Eur, Mid-East, Afr M - OptEx $0.00 -12.9K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-10 M A 12,931 $16.31 44,352.99 D — —
2 Common Common Stock 2024-05-10 S D 12,931 $74.14 31,421.99 D — — (F1) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $74.13 to $74.165, inclusive. The reporting person undertakes to provide upon request bythe U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
3 Derivative Stock Option (Right to Buy) 2024-05-10 M D 12,931 $0.00 0 D $16.31 · — to 2025-02-23 12,931 Common Stock (F2) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.